{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:27:48Z","timestamp":1791390468190,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.urolonc.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:11:25Z","timestamp":1441757485000},"page":"4.e11-4.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity"],"prefix":"10.1016","volume":"34","author":[{"given":"Noah M.","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice S.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Daneshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael O.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bihrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Corless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajjai S.","family":"Alva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Gertych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Gallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayati","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Galsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth P.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin M.","family":"Posadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guru","family":"Sonpavde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2015.08.005_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2015.08.005_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party tEOfR","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.08.005_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","author":"Vale","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.08.005_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cncr.22031","article-title":"Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder","volume":"107","author":"Dash","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2015.08.005_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5489\/cuaj09134","article-title":"Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline","volume":"4","author":"Miles","year":"2010","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2015.08.005_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.eururo.2014.01.009","article-title":"Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides","volume":"67","author":"Reardon","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.08.005_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.juro.2007.03.101","article-title":"Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base","volume":"178","author":"David","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/sj.onc.1205298","article-title":"Src kinase contributes to the metastatic spread of carcinoma cells","volume":"21","author":"Boyer","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2015.08.005_bib10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/1535-7163.MCT-10-0096","article-title":"Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling","volume":"9","author":"Levitt","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urolonc.2015.08.005_bib11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/0008-5472.CAN-10-0730","article-title":"Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer","volume":"71","author":"Thomas","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2015.08.005_bib12","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1073\/pnas.0810094106","article-title":"Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function","volume":"106","author":"Wu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/bjc.2012.52","article-title":"The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder","volume":"106","author":"Qayyum","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2015.08.005_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.clinthera.2007.11.005","article-title":"Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"29","author":"Steinberg","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.urolonc.2015.08.005_bib16","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/cncr.24466","article-title":"Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy","volume":"115","author":"Sonpavde","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2015.08.005_bib17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.juro.2007.10.076","article-title":"Outcome after radical cystectomy with limited or extended pelvic lymph node dissection","volume":"179","author":"Dhar","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.08.005_bib18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ijrobp.2014.01.001","article-title":"Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base","volume":"88","author":"Gray","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2015.08.005_bib19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.08.005_bib20","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1158\/1940-6207.CAPR-11-0267","article-title":"Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer","volume":"4","author":"Saini","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.urolonc.2015.08.005_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jnci\/djn451","article-title":"Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer","volume":"101","author":"Margulis","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2015.08.005_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1470-2045(07)70002-5","article-title":"Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy","volume":"8","author":"Karam","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2015.08.005_bib23","first-page":"365","article-title":"Elevated c-Src protein expression is an early event in colonic neoplasia","volume":"78","author":"Iravani","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/j.urolonc.2015.08.005_bib24","first-page":"1457","article-title":"Elevated expression of pp60c-src in low grade human bladder carcinoma","volume":"52","author":"Fanning","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2015.08.005_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915004020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915004020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:07:19Z","timestamp":1761041239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915004020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1078143915004020"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.08.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}